This Article Full Text (OnlineFirst PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Krivokuca, I. Articles by Lammers, J.-W. J. PubMed PubMed Citation Articles by Krivokuca, I. Articles by Lammers, J.-W. J. Social Bookmarking                         What's this?

Recurrent Pulmonary Embolism Associated With a Hemostatic Drug: Tranexamic Acid

^* To whom correspondence should be addressed. E-mail: i.krivokuca{at}umcutrecht.nl.

	Abstract

Tranexamic acid (TA) used in a variety of conditions associated with bleeding has been associated with potential thrombotic side effects such as formation of thrombi and pulmonary embolism (PE). We describe a case of a woman with chronic hemoptysis and a history of PE, who recently used TA as a prophylactic measure, which could have resulted in a new episode of PE. Tranexamic acid probably played a contributory role in the development of her second PE.

First published on October 14, 2009
Clinical and Applied Thrombosis/Hemostasis 2009, doi:10.1177/1076029609340902


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?